Breakthrough design vastly improves mechanical heart valve
New research coming out of UBC's Okanagan campus may take the current 'gold standard' for heart valves to a new level of reliability.
Jan 26, 2021
0
2
New research coming out of UBC's Okanagan campus may take the current 'gold standard' for heart valves to a new level of reliability.
Jan 26, 2021
0
2
Non-degradable prostheses for cardiovascular tissues can be used to replace heart valves and blood vessels, but they can't stay in the body permanently. In two recent papers, TU/e researchers in collaboration with a number ...
Jan 8, 2021
0
74
Options to treat heart valve disease are expanding, allowing patients to avoid surgery when possible, according to a new joint clinical practice guideline from the American College of Cardiology and the American Heart Association. ...
Dec 18, 2020
0
2
Calcific aortic valve disease is not only the most common valve disease in the elderly, it's also the third leading cause of heart disease overall. For those affected, calcium starts to accumulate in their heart valves and ...
Dec 10, 2020
0
131
Stephanie Harris was six months pregnant and in the hospital with excruciating pain. But it wasn't the baby, it was kidney stones.
Dec 8, 2020
0
5
Aortic stenosis is one of the most common heart valve defects. Its prevalence increases with age and it often requires treatment. As well as conventional valve replacement involving open-heart surgery, a less invasive procedure ...
Nov 24, 2020
0
0
Since the approval of the first transcatheter aortic valve replacement (TAVR) device in 2011, more than 276,000 patients have undergone a TAVR procedure in the United States. According to a report from The Society of Thoracic ...
Nov 16, 2020
0
1
The primary results from the RIVER Trial, Rivaroxaban for Valvular Heart disease and Atrial Fibrillation, show that rivaroxaban is comparable to warfarin, which is currently the standard of care anticoagulant prescribed for ...
Nov 16, 2020
0
1
In a randomized clinical trial, SCOPE II, a new self-expanding bioprosthetic valve used in transcatheter aortic valve replacement (TAVR) failed to demonstrate non-inferiority compared to an existing self-expanding valve.
Oct 16, 2020
0
0
The MITHRAS randomized clinical trial found that interventional closure of an iatrogenic atrial septal defect (iASD) driven by transcatheter mitral valve repair (TMVR) was not superior to conservative medical treatment with ...
Oct 16, 2020
0
0